Translational Development Acquisition Corp.
Organization details
- Legal name
- Translational Development Acquisition Corp.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Financials
- SIC code
- 6770 — Blank Checks
- Headquarters city
- New York
- Headquarters state / province
- New York
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- TDAC
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001926599
Board of directors
-
Christopher Kenneth Jarratt · DirectorSince 2024
-
Curtis T. Keith · DirectorSince 2024
-
E. Premkumar Reddy · DirectorSince 2024
-
Matthew Kestenbaum · DirectorSince 2024
-
Michael B. Hoffman · Director · Chairman and CEOSince 2024
Chief executives
Board connections
1 of this board's directors also sit on 1 other board.
- via Michael B. Hoffman
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Translational Development Acquisition Corp.
Who is the CEO of Translational Development Acquisition Corp.?
Michael B. Hoffman has been Translational Development Acquisition Corp.'s Chief Executive Officer since December 2024.
How many directors are on Translational Development Acquisition Corp.'s board?
Translational Development Acquisition Corp.'s board has 5 directors: Christopher Kenneth Jarratt, Curtis T. Keith, E. Premkumar Reddy, Matthew Kestenbaum and Michael B. Hoffman.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="translational-development-acquisition-corp"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.